Amos Hedt

Chief Business Strategy Officer

‍Viewpoint Molecular Targeting, Inc.

Chief Business Strategy Officer

‍Viewpoint Molecular Targeting, Inc.

#theranostics #drugdevelopment #targetedtherapy #radiopharmaceuticals

#NorthAmerica

Mr. Hedt is an experienced research professional with over 20 years in the biotechnology and pharmaceutical industries and a comprehensive understanding of all stages of drug research, development, an

Thierry Pronce

Director, Quality and Digital Strategy for Analytical R&D

‍GSK

Director, Quality and Digital Strategy for Analytical R&D

‍GSK

#radiopharmaceuticals #

#Europe

Ph. D. thesis in Pharmaceutical Sciences with strong knowledge of pharmaceutical analysis.

Volker Wagner

Vice President, Head of Clinical Development Radiopharmaceuticals

‍Bayer Pharmaceuticals

Vice President, Head of Clinical Development Radiopharmaceuticals

‍Bayer Pharmaceuticals

#Radiopharmaceuticals

#Europe

Volker Wagner, MD, PhD is the Head of Clinical Development Radiopharmaceuticals at Bayer. He is responsible for Bayer’s Targeted Radionuclide Therapies across early and late stage development.